Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

LEL

Lilly(Eli) (LEL)

Lilly(Eli)
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:LEL
DateTimeSourceHeadlineSymbolCompany
01/30/20148:27AMPR Newswire (US)LILLY (ELI) & COMPANY - 4th Quarter EarningsLSE:LELLilly(Eli)
07/25/20131:00AMPR Newswire (US)LILLY (ELI) & COMPANY - Half-yearly ReportLSE:LELLilly(Eli)
07/08/20139:17AMPR Newswire (US)LILLY (ELI) & COMPANY - Form 8-KLSE:LELLilly(Eli)
05/08/20139:06AMPR Newswire (US)LILLY (ELI) & COMPANY - Doc re Form 8K FilingLSE:LELLilly(Eli)
05/07/20139:22AMPR Newswire (US)LILLY (ELI) & COMPANY - CEO Lechleiter to undergo surgeryLSE:LELLilly(Eli)
05/03/20131:00AMPR Newswire (US)LILLY (ELI) & COMPANY - Doc re Proxy StatementsLSE:LELLilly(Eli)
05/03/20131:00AMPR Newswire (US)LILLY (ELI) & COMPANY - 1st Quarter ResultsLSE:LELLilly(Eli)
04/24/201310:31AMPR Newswire (US)LILLY (ELI) & COMPANY - Doc re Form 8-K FilingLSE:LELLilly(Eli)
03/28/20138:35AMUK RegulatoryLilly (Eli) & Co Cancellation of ListingLSE:LELLilly(Eli)
03/28/20138:35AMPR Newswire (US)LILLY (ELI) & COMPANY - Cancellation of ListingLSE:LELLilly(Eli)
03/28/20133:00AMUK RegulatoryOfficial List Cancellation Lilly (Eli) & CompanyLSE:LELLilly(Eli)
03/26/201311:01AMPR Newswire (US)LILLY (ELI) & COMPANY - Doc re Proxy StatementsLSE:LELLilly(Eli)
03/26/201311:00AMPR Newswire (US)LILLY (ELI) & COMPANY - Statement re Intention to Cancel Listing of SharesLSE:LELLilly(Eli)
02/27/201311:06AMPR Newswire (US)LILLY (ELI) & COMPANY - Statement re Intention to Cancel ListingLSE:LELLilly(Eli)
02/07/20137:59AMPR Newswire (US)LILLY (ELI) & COMPANY - Phase 3 RA Program discontinued for TabalumabLSE:LELLilly(Eli)
01/29/20137:33AMPR Newswire (US)LILLY (ELI) & COMPANY - Lilly Reports Q4 and Full-Year 2012 ResultsLSE:LELLilly(Eli)
01/24/201312:24PMPR Newswire (US)LILLY (ELI) & COMPANY - Miscellaneous - Other SEC FilingsLSE:LELLilly(Eli)
01/24/201312:22PMPR Newswire (US)LILLY (ELI) & COMPANY - Holding(s) in CompanyLSE:LELLilly(Eli)
01/24/201312:21PMPR Newswire (US)LILLY (ELI) & COMPANY - Doc re Form 8-K FilingsLSE:LELLilly(Eli)
01/24/201312:19PMPR Newswire (US)LILLY (ELI) & COMPANY - Director/PDMR ShareholdingLSE:LELLilly(Eli)
01/24/201312:16PMPR Newswire (US)LILLY (ELI) & COMPANY - Doc re Proxy StatementLSE:LELLilly(Eli)
01/24/201312:15PMPR Newswire (US)LILLY (ELI) & COMPANY - 3rd Quarter ResultsLSE:LELLilly(Eli)
01/24/201312:13PMPR Newswire (US)LILLY (ELI) & COMPANY - 1st Quarter ResultsLSE:LELLilly(Eli)
01/24/201312:12PMPR Newswire (US)LILLY (ELI) & COMPANY - Half-yearly ReportLSE:LELLilly(Eli)
01/24/201312:11PMPR Newswire (US)LILLY (ELI) & COMPANY - Annual Financial ReportLSE:LELLilly(Eli)
01/24/201312:02PMPR Newswire (US)LILLY (ELI) & COMPANY - Annual Information Update 2012LSE:LELLilly(Eli)
01/24/201311:39AMPR Newswire (US)LILLY (ELI) & COMPANY - Annual Information Update 2011LSE:LELLilly(Eli)
01/24/201311:37AMPR Newswire (US)LILLY (ELI) & COMPANY - Annual Information Update 2010LSE:LELLilly(Eli)
01/16/20131:00AMPR Newswire (US)LILLY (ELI) & COMPANY - Amyvid Approved in European UnionLSE:LELLilly(Eli)
01/07/20138:11AMPR Newswire (US)LILLY (ELI) & COMPANY - Phase III data results for empagliflozinLSE:LELLilly(Eli)
 Showing the most relevant articles for your search:LSE:LEL